AstraZeneca’s Sustainability Advances with AI in Drug Development
AstraZeneca cuts emissions by 88% while accelerating drug discovery with AI AstraZeneca has reduced its Scope 1 and 2 emissions by 88% since 2015 while simultaneously cutting drug discovery timelines […]
AstraZeneca’s Sustainability Advances with AI in Drug Development Read More »










